Webinar | April 11, 2017

Bench to Clinic – Preclinical & First-in-Man Drug Development Strategies

Source: Catalent
Bench to Clinic

Early phase development strategy should start with a thoughtful analysis of the drug substance, pre-formulation data, desired clinical outcomes and the strategic goals of the company. In this webinar, industry experts discuss several factors that impact early phase development and clinical success, including case studies and methods for developing a sound, phase-appropriate formulation with scientifically supportable data to help progress development to the next phase in a timely and cost-efficient manner.